Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Fujimi
Benefit Profile of Recombinant Human Soluble Thrombomodulin in Sepsis-Induced DIC
Critical Care
Critical Care
Intensive Care Medicine
Related publications
Combination Effect of Antithrombin and Recombinant Human Soluble Thrombomodulin in a Lipopolysaccharide Induced Rat Sepsis Model
Critical Care
Critical Care
Intensive Care Medicine
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
JAMA - Journal of the American Medical Association
Medicine
Drug-Induced Thrombotic Thrombocytopenic Purpura Successfully Treated With Recombinant Human Soluble Thrombomodulin
Internal Medicine
Internal Medicine
Medicine
Phase I Study of Solulin, a Novel Recombinant Soluble Human Thrombomodulin Analogue
Thrombosis and Haemostasis
Hematology
Enhanced Effect of Recombinant Human Soluble Thrombomodulin by Ultrasound Irradiation in Acute Liver Failure
Scientific Reports
Multidisciplinary
Clinical Outcomes of Recombinant Human-Soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors
Anticancer Research
Medicine
Cancer Research
Oncology
Septic Disseminated Intravascular Coagulation (DIC) and Thrombomodulin
Journal of the Japanese Society of Intensive Care Medicine
Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated With Infectious Systemic Inflammatory Response Syndromes
Journal of Clinical Medicine
Soluble Variants of Human Recombinant Glutaminyl Cyclase
PLoS ONE
Multidisciplinary
